Porphyrin Photosensitizers in Photodynamic Therapy and Its Applications

Overview

Journal Oncotarget

Specialty Oncology

Date 2017 Nov 9

PMID 29113417

Citations 151

Authors

Jiayuan Kou

Dou Dou

Liming Yang

Affiliations

Soon will be listed here.

Abstract

In 1841, the extraction of hematoporphyrin from dried blood by removing iron marked the birth of the photosensitizer. The last twenty years has witnessed extensive research in the application of photodynamic therapy (PDT) in tumor-bearing (or other diseases) animal models and patients. The period has seen development of photosensitizers from the first to the third generation, and their evolution from simple to more complex entities. This review focuses on porphyrin photosensitizers and their effect on tumors, mediated via several pathways involved in cell necrosis, apoptosis or autophagic cell death, and the preventive and therapeutic application of PDT against atherosclerosis.

Citing Articles

Cancer-targeted pro-theranostic bi-metallic organo-coordination nanoparticles.

Huang H, Fang L, Wansapura J, Prior J, Manion B, Xu B Theranostics. 2025; 15(4):1205-1220.

PMID: 39816680 PMC: 11729564. DOI: 10.7150/thno.99863.

An esophageal stent integrated with wireless battery-free movable photodynamic-therapy unit for targeted tumor treatment.

Han Q, Zou P, Wei X, Chen J, Li X, Quan L Mater Today Bio. 2025; 30:101394.

PMID: 39759842 PMC: 11697610. DOI: 10.1016/j.mtbio.2024.101394.

Preclinical Photodynamic Therapy Targeting Blood Vessels with AGuIX Theranostic Nanoparticles.

Kowolik E, Szczygiel D, Szczygiel M, Drzal A, Vemuri K, Olsson A Cancers (Basel). 2024; 16(23).

PMID: 39682113 PMC: 11640380. DOI: 10.3390/cancers16233924.

Advancing Photodynamic Therapy with Nano-Conjugated Hypocrellin: Mechanisms and Clinical Applications.

Rajan S, Chandran R, Abrahamse H Int J Nanomedicine. 2024; 19:11023-11038.

PMID: 39502636 PMC: 11537162. DOI: 10.2147/IJN.S486014.

Review on Photoacoustic Monitoring after Drug Delivery: From Label-Free Biomarkers to Pharmacokinetics Agents.

Kim J, Choi S, Kim C, Kim J, Park B Pharmaceutics. 2024; 16(10).

PMID: 39458572 PMC: 11510789. DOI: 10.3390/pharmaceutics16101240.

References

Usui M, Asahara T, Naitoh Y, Katoh T, Ibukiyama C . Photodynamic therapy for the prevention of intimal hyperplasia in balloon-injured rabbit arteries. Jpn Circ J. 2000; 63(5):387-93. DOI: 10.1253/jcj.63.387. View

Lilletvedt M, Tonnesen H, Hogset A, Nardo L, Kristensen S . Physicochemical characterization of the photosensitizers TPCS2a and TPPS2a 1. Spectroscopic evaluation of drug--solvent interactions. Pharmazie. 2010; 65(8):588-95. View

Inoue K, Fukuhara H, Kurabayashi A, Furihata M, Tsuda M, Nagakawa K . Photodynamic therapy involves an antiangiogenic mechanism and is enhanced by ferrochelatase inhibitor in urothelial carcinoma. Cancer Sci. 2013; 104(6):765-72. PMC: 7657171. DOI: 10.1111/cas.12147. View

Maiolino S, Moret F, Conte C, Fraix A, Tirino P, Ungaro F . Hyaluronan-decorated polymer nanoparticles targeting the CD44 receptor for the combined photo/chemo-therapy of cancer. Nanoscale. 2015; 7(13):5643-53. DOI: 10.1039/c4nr06910b. View

Nishiyama N, Morimoto Y, Jang W, Kataoka K . Design and development of dendrimer photosensitizer-incorporated polymeric micelles for enhanced photodynamic therapy. Adv Drug Deliv Rev. 2009; 61(4):327-38. DOI: 10.1016/j.addr.2009.01.004. View

Lilletvedt M, Tonnesen H, Hogset A, Sande S, Kristensen S . Evaluation of physicochemical properties and aggregation of the photosensitizers TPCS2a and TPPS2a in aqueous media. Pharmazie. 2011; 66(5):325-33. View

Komagoe K, Kato H, Inoue T, Katsu T . Continuous real-time monitoring of cationic porphyrin-induced photodynamic inactivation of bacterial membrane functions using electrochemical sensors. Photochem Photobiol Sci. 2011; 10(7):1181-8. DOI: 10.1039/c0pp00376j. View

Schmidt-Erfurth U, Miller J, Sickenberg M, Bunse A, Laqua H, Gragoudas E . Photodynamic therapy of subfoveal choroidal neovascularization: clinical and angiographic examples. Graefes Arch Clin Exp Ophthalmol. 1998; 236(5):365-74. DOI: 10.1007/s004170050092. View

Diez Valle R, Slof J, Galvan J, Arza C, Romariz C, Vidal C . Observational, retrospective study of the effectiveness of 5-aminolevulinic acid in malignant glioma surgery in Spain (The VISIONA study). Neurologia. 2013; 29(3):131-8. DOI: 10.1016/j.nrl.2013.05.004. View

10.

Senge M . mTHPC--a drug on its way from second to third generation photosensitizer?. Photodiagnosis Photodyn Ther. 2012; 9(2):170-9. DOI: 10.1016/j.pdpdt.2011.10.001. View

11.

Chissov V, Sokolov V, Filonenko E, Menenkov V, Zharkova N, Kozlov D . [Clinical fluorescent diagnosis of tumors using photosensitizer photogem]. Khirurgiia (Mosk). 1995; (5):37-41. View

12.

Lin J, Wang S, Huang P, Wang Z, Chen S, Niu G . Photosensitizer-loaded gold vesicles with strong plasmonic coupling effect for imaging-guided photothermal/photodynamic therapy. ACS Nano. 2013; 7(6):5320-9. PMC: 3709863. DOI: 10.1021/nn4011686. View

13.

Stylli S, Howes M, MacGregor L, Rajendra P, Kaye A . Photodynamic therapy of brain tumours: evaluation of porphyrin uptake versus clinical outcome. J Clin Neurosci. 2004; 11(6):584-96. DOI: 10.1016/j.jocn.2004.02.001. View

14.

Nardo L, Kristensen S, Tonnesen H, Hogset A, Lilletvedt M . Solubilization of the photosensitizers TPCS(2a) and TPPS(2a) in aqueous media evaluated by time-resolved fluorescence analysis. Pharmazie. 2012; 67(7):598-600. View

15.

Bialy D, Derkacz A, Wawrzynska M, Bednarkiewicz A, Ziolkowski P, Nowosad H . In vitro photodynamic diagnosis of atherosclerotic wall changes with the use of mono-l-aspartyl chlorin e6. A preliminary report. Kardiol Pol. 2003; 59(10):293-301. View

16.

Allison R, Sibata C . Oncologic photodynamic therapy photosensitizers: a clinical review. Photodiagnosis Photodyn Ther. 2010; 7(2):61-75. DOI: 10.1016/j.pdpdt.2010.02.001. View

17.

Tournas J, Lai J, Truitt A, Huang Y, Osann K, Choi B . Combined benzoporphyrin derivative monoacid ring photodynamic therapy and pulsed dye laser for port wine stain birthmarks. Photodiagnosis Photodyn Ther. 2009; 6(3-4):195-9. PMC: 2784424. DOI: 10.1016/j.pdpdt.2009.10.002. View

18.

Berg K, Selbo P, Weyergang A, Dietze A, Prasmickaite L, Bonsted A . Porphyrin-related photosensitizers for cancer imaging and therapeutic applications. J Microsc. 2005; 218(Pt 2):133-47. DOI: 10.1111/j.1365-2818.2005.01471.x. View

19.

Price M, Heilbrun L, Kessel D . Effects of the oxygenation level on formation of different reactive oxygen species during photodynamic therapy. Photochem Photobiol. 2012; 89(3):683-6. PMC: 3604127. DOI: 10.1111/php.12027. View

20.

Star W . Light dosimetry in vivo. Phys Med Biol. 1997; 42(5):763-87. DOI: 10.1088/0031-9155/42/5/003. View